Larynx Cancer Clinical Trial
Official title:
Randomized Study Comparing Induction Chemotherapy With Docetaxel, Cisplatin, 5FU Versus Cisplatin, 5 FU in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma
The purpose of the study is to compare two regimen of chemotherapy used as first treatment for patients with larynx or hypopharynx tumors that would be treated with total laryngectomy. The standard treatment is a combination of 2 drugs (Cisplatin and 5FU). The aim of the study is to evaluate the potential benefit of the addition of a third drug (Docetaxel) in the chemotherapy regimen. Patients will receive 3 cycles of chemotherapy. Responders to the induction treatment are treated with radiation with a purpose of larynx preservation. Non responders patients will be treated with total laryngectomy.
The purpose of the study is to compare two regimen of induction chemotherapy for patients with T3 and T4 larynx or hypopharynx carcinoma that would be treated with total laryngectomy. The aim of the study is to compare the standard regimen (Cisplatin + 5FU) versus the TPF regimen (Taxotere + Cisplatin + 5FU). Responders to the induction treatment are treated with radiation with a purpose of larynx preservation. Non responders patients will be treated with total laryngectomy followed by postoperative radiation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06016699 -
Immunological Function After Radiation With Either Proton or Photon Therapy
|
||
| Completed |
NCT03292341 -
Evaluation of a Web-based Decision Aid Tool for Larynx Cancer (T3/T4) Patients.
|
N/A | |
| Completed |
NCT03653039 -
Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct Laryngoscopy
|
N/A | |
| Completed |
NCT05746780 -
Bilateral Elective Neck Dissection in Salvage Total Laryngectomy
|
||
| Recruiting |
NCT05793151 -
Multi-Site Trial of Navigation vs Treatment as Usual for Delays in Starting Adjuvant Therapy
|
N/A | |
| Completed |
NCT01700647 -
Breath Testing in Early and Late Larynx Cancer
|
N/A | |
| Completed |
NCT00169247 -
Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation
|
Phase 2 | |
| Completed |
NCT00600223 -
Functional Voice and Speech Outcomes Following Surgical Voice Restorations: A Comparison of Pharyngeal Construction Approaches
|
N/A | |
| Recruiting |
NCT03759431 -
Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT02586207 -
Pembrolizumab in Combination With CRT for LA-SCCHN
|
Phase 1 | |
| Recruiting |
NCT04057209 -
VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer
|
N/A | |
| Recruiting |
NCT04028479 -
The Registry of Oncology Outcomes Associated With Testing and Treatment
|
||
| Recruiting |
NCT06086119 -
Quality of Life and Voice Perception in Patients Laryngoctomized Phonatory Wearers
|
||
| Suspended |
NCT04368702 -
CONFIRM: Magnetic Resonance Guided Radiation Therapy
|
N/A | |
| Completed |
NCT05217147 -
An Investigation of Biomarker Candidate Molecules in Laryngeal Carcinoma
|
||
| Active, not recruiting |
NCT03082534 -
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
|
Phase 2 | |
| Completed |
NCT00158652 -
Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC
|
Phase 3 | |
| Terminated |
NCT03479463 -
Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy
|
||
| Completed |
NCT03096808 -
Adaptive Radiotherapy for Head and Neck Cancer
|
Phase 2 | |
| Completed |
NCT03028766 -
WEE1 Inhibitor With Cisplatin and Radiotherapy: A Trial in Head and Neck Cancer
|
Phase 1 |